相关实验视频

Updated: Jan 17, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

疾病控制和可管理的毒性与epcoritamab在耐火扩散大B细胞淋巴瘤-型里希特综合征:一个病例报告在一个老年患者

Takumi Nishikawa1, Masuho Saburi1, Shogo Urabe2

  • 1Department of Hematology, Oita Prefectural Hospital, Oita, Japan.

Cancer reports (Hoboken, N.J.)
|September 16, 2025
PubMed
概括

埃普科里塔马布在治疗耐火性扩散性大B细胞淋巴瘤-里希特综合征 (DLBCL-RS) 的老年患者方面表现有前途. 这种双特异性抗体实现了部分反应,为这种侵袭性癌症提供了新的治疗选择.

关键词:
里希特综合征是什么 里希特综合征是什么慢性淋巴细胞白血病 慢性淋巴细胞白血病扩散的大B细胞淋巴瘤经过多年的研究,Epcoritamab.小型淋巴细胞淋巴瘤.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.7K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K